News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemagen Diagnostics, Inc. (HMGN) Extends Exchange Offer For 8% Senior Subordinated Secured Convertible Notes Due April 2005 And Increases Interest Rate On Modified Notes


10/19/2005 5:12:22 PM

Hemagen Diagnostics, Inc., (NASDAQ OTCBB:HMGN.OB) announced today that it has extended its offer to exchange $6,090,000 principal amount of its 8% Senior Subordinated Secured Convertible Notes due 2005 (the "Notes") for common stock and Modified Notes. The exchange offer, as previously extended, was scheduled to expire at 12:00 midnight, Eastern Time, on December 3, 2004. The new expiration date for the exchange offer is 12:00 midnight, Eastern Time, on December 17, 2004, unless further extended or earlier terminated. In addition, Hemagen announced that it also increased the interest rate that would be payable on the Modified Notes to 8% per year from 6% per year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES